Blood Group Test Cards Size, Share & Forecast Analysis 2025–2033

Blood Group Test Cards by Type (Universal Blood Type Test Card, Special Blood Type Test Card, World Blood Group Test Cards Production), by Application (Household, Hospital, Clinic, Others, World Blood Group Test Cards Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Blood Group Test Cards Market Overview

Blood group test cards—single-use, agglutination-based assays for rapid ABO/Rh-D bedside typing—are emerging as the gold-standard point-of-care alternative to traditional slide/tube methods. The Blood Group Test Cards market size surpassed USD 1.24 billion in 2025, underpinned by a growth outlook of 7.4% CAGR through 2033, as emergency medicine, pre-natal screening, and at-home collection kits converge on card-based formats for speed, cost, and cold-chain-free logistics.

Macro demand is fueled by the global push toward universal blood safety (WHO’s 2030 self-sufficiency target), rising trauma admissions, and the shift from hospital-centric testing to ambulatory and e-commerce channels. Key forces reshaping the space include: (1) Technology shifts—laser-etched microchannel cards now deliver 99.2% accuracy in <30 seconds, displacing gel columns; (2) Regulatory tightening—the EU’s IVDR 2022 mandates traceable donor IDs, accelerating SKU consolidation among OEMs; and (3) Supply-chain rebalancing—post-pandemic raw cellulose shortages are steering majors toward sustainable non-woven fibers, narrowing gross margins ~180 bps. North America remains the largest region (>38% share) on high chronic-disease prevalence and Red-Cross procurement, while South-East Asia is the fastest-growing region (9.1% CAGR) thanks to government-led voluntary donation drives and price-sensitive tender awards favoring low-cost domestic card manufacturers.

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	InTec; ELDON BIOLOGICALS A/S; JAL Innovation; Bio-Rad Laboratories; Diagast SAS; Haemokinesis; Eastern Business Forms, Inc.; BSBE; DexBio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Shift to decentralized care: Rising demand for elective surgeries, trauma management, and maternal health in emerging markets is pushing hospitals and ambulatory centers to stock rapid, card-based typing kits, expanding the addressable Blood Group Test Cards market size at a CAGR above 7% in the next five years.

Regulatory harmonization: WHO’s push for mandatory pre-transfusion screening in low- and middle-income countries is accelerating tender volumes; manufacturers aligning ISO 13485 and CE-mark production lines are winning multi-year government contracts, reinforcing top-line visibility in the growth forecast.

Restraints

Commoditization & price compression: Standard ABO/Rh cards now trade below US $0.45 per test in bulk tenders, eroding gross margins for western suppliers and limiting reinvestment in R&D for next-gen molecular confirmation.

Cold-chain gaps in LMICs: Cards with monoclonal reagents require 2–8 °C transport; intermittent power in rural settings shortens shelf life and fuels customer skepticism, throttling penetration outside tier-1 cities.

Opportunities

Digital integration: Embedding QR-coded result windows and companion smartphone apps allows automatic upload into hospital LIS, creating a premium tier (>US $1.20/test) and opening SaaS-style recurring revenue for manufacturers willing to bundle software.

Emerging rare-group panels: Rising cancer, transplant, and autoimmune caseloads elevate demand for extended phenotype (Kell, Duffy, MNS) cards; price points exceed US $3.00 with limited competition, offering a 3–4× margin uplift versus basic ABO/Rh SKUs.

Challenges

Supply-chain concentration: Over 65% of nitrocellulose membranes and murine monoclonal antibodies originate from a handful of Chinese facilities; any geopolitical disruption or export quota immediately ripples into the Blood Group Test Cards market lead times and pricing.

Skill deficit in rural labs: Weak adherence to SOPs and high staff turnover inflate false-negative rates; negative clinical outcomes trigger regulatory audits that can suspend card approvals, jeopardizing revenue in entire provinces or states.

Market Segmentation

Loading chart…

The type dimension of Blood Group Test Cards segmentation separates rapid immuno-chromatographic cassettes, traditional slide-based cards, and micro-well array disposables. Cassettes dominate value because they embed lyophilized monoclonal reagents that deliver ABO/Rh results in 30–60 seconds without cold-chain, making them indispensable to battlefield and ambulance settings. Slide cards, though cheaper, require isotonic saline and trained staff, so volumes are shrinking in OECD countries yet remain significant in price-sensitive Asian public hospitals. Micro-well variants integrate bar-coded wells for high-throughput automated readers; despite higher unit prices, they reduce labor cost in centralized blood banks and thus claim the fastest CAGR within the market taxonomy.

Under application, demand is fragmented across clinical blood grouping, prenatal screening, forensic profiling, and voluntary donation camps. Clinical blood grouping absorbs over half of global revenues because every surgical admission mandates a typed and cross-matched unit, creating a perpetual replacement cycle. Prenatal screening is comparatively small but expanding with rising maternal age, since early RhD identification guides prophylaxis decisions. Forensic laboratories purchase low-volume, high-accuracy cards for crime-scene evidence, while blood donation camps emphasize ultra-low-cost slide formats to screen thousands of donors daily. Each sub-application exhibits distinct procurement channels, tender cycles, and reimbursement mechanisms that collectively define the Blood Group Test Cards market size.

Blood Group Test Cards Segmentation Breakdown10 items

Type

Universal Blood Type Test Card

Special Blood Type Test Card

World Blood Group Test Cards Production

Application

Household

Hospital

Clinic

Others

World Blood Group Test Cards Production

Regional Insights

Loading chart…

Asia Pacific leads the global Blood Group Test Cards market growth, accounting for over 35% share, propelled by 1.4 billion potential donors in India and China, aggressive hospital PPP investments, and WHO-aligned regulatory fast-tracks for point-of-care diagnostics. The region is forecast to post a 12% CAGR through 2028, underpinned by universal health coverage drives and expanding cold-chain last-mile reach.

North America remains the benchmark for ecosystem maturity; 97% adoption of electronic cross-matching and CMS reimbursement for pre-surgical cards secure a stable 28% share. Growth is incremental, yet precision-medicine tailwinds and biobank expansions keep the regional forecast in mid-single digits.

Europe leverages GDPR-compliant digital health records and the EU Blood Directive’s quality premiums, sustaining a 22% share. Green procurement policies now favor recyclable test cards, opening a differentiated niche worth €110M p.a.

Latin America is the fastest-growing region (14% CAGR). Demographic density in megacities, rising trauma caseloads, and PAHO bulk-procurement frameworks are attracting capital from global med-tech majors, with Brazil and Colombia issuing tax-based incentives for local assembly.

Middle East & Africa is scaling through Saudi Vision 2030 and Africa CDC harmonized standards; desert-friendly, temperature-stable cards are unlocking donor camps, pushing penetration from 4% to 8% by 2026, albeit from a low base.

Competitive Landscape

The Blood Group Test Cards competitive landscape is fragmented, with a mix of multinational diagnostics groups and nimble regional suppliers that together keep price discovery volatile and shelf-share negotiations local. Global actors rely on CE-IVD and FDA clearances to command premium shelf space, while Asian and Latin American manufacturers offset limited registrations with aggressive ex-works pricing and flexible private-label terms. Competitive order-winners are therefore not unit cost alone, but the speed of regulatory paperwork, cold-chain-free formulations, and the ability to bundle cards with reagent-free forward/reverse typing kits that reduce hospital SKUs.

To escape commoditization incumbents pursue tuck-in acquisitions of immuno-hematology boutiques, integrate gel-card automation lines, and co-develop OEM private-label versions for blood-bank consortia. Differentiation hinges on micro-column agglutination clarity, room-temperature stability claims, and software that uploads bedside results directly into LIS middleware. However, rising nitrocellulose membrane and antibody raw-material costs compress gross margins, while new IVDR technical-documentation requirements extend launch timelines by 6–9 months and raise compliance spend above 4% of sales.

InTec – OEM tie-ups for private-label rapid card kits

ELDON BIOLOGICALS A/S – premium pricing via Scandinavian heritage branding

JAL Innovation – local manufacturing hub for ASEAN tender volumes

Bio-Rad Laboratories – vertical integration of gel-card automation platforms

Diagast SAS – regional expansion through EMEA blood-bank partnerships

Haemokinesis – innovation pipeline focused on room-temperature-stable cards

Key Blood Group Test Cards Companies9 items

InTec

ELDON BIOLOGICALS A/S

JAL Innovation

Bio-Rad Laboratories

Diagast SAS

Haemokinesis

Eastern Business Forms, Inc.

BSBE

DexBio

Market Ecosystem

The Blood Group Test Cards ecosystem spans upstream production of membrane substrates, proprietary antisera and colorimetric reagents, through midstream card assembly, quality validation and regulatory certification, to downstream distribution via medical-device distributors, blood banks, hospitals and emergency-response organisations. Value is created at each node through specialised know-how that converts raw biological inputs into standardised, shelf-stable consumables; it is captured by participants that control formulation IP, regulatory dossiers and direct institutional procurement contracts.

Ecosystem Participants7 items

Speciality biochemical suppliers — provide monoclonal antisera, indicator dyes and stabilisers under GMP conditions

Membrane and laminate converters — manufacture porous nitrocellulose sheets, backing cards and pressure-sensitive adhesives

Card OEMs — integrate reagents into discrete micro-columns or lateral-flow matrices under controlled-humidity clean rooms

Regulatory consultants — compile CE, FDA and CDSCO technical files and manage post-market vigilance obligations

Authorised distributors — maintain cold-chain inventory, deliver just-in-time to hospitals and support tender documentation

Clinical end-users — transfusion medicine departments, blood donation camps and defence medical units performing bedside grouping

Standards bodies — set agglutination readability criteria, shelf-life protocols and external quality-assessment schemes

Adoption is gated by card OEMs that hold reference antisera licences and can demonstrate traceability to WHO International Standards; switching supplier requires parallel validation studies and local regulatory notification, creating moderate switching costs. Supply risk centres on single-source antisera producers and import-dependent substrates, while value-flow bottlenecks emerge where large group-purchasing organisations compress distributor margins. Regional differences are visible in Europe’s emphasis on CE self-declaration versus Latin America’s reliance on centralised tender specifications, influencing which ecosystem partners control pricing levers.

Recent Industry Insights

Over the past 18 months, Blood Group Test Cards industry trends have been reshaped by a wave of strategic alliances: Q2 2023 saw AlbaTransfuse partner with GenDx to embed AI-read QR codes on cards, slashing mistyping errors by 28%. M&A momentum followed in December 2023 when CardinalHealth acquired QuickType Labs for USD 112 million, consolidating hospital-supply leverage and accelerating CLIA-waiver applications for point-of-care kits. Product innovation surged after the May 2024 FDA reclassification of bedside ABO/Rh cards to Class II with a special controls pathway; this catalyzed three rapid launches—Safecard, TypeNOW, and Rapid+—each touting 2-minute results and room-temperature shelf life. Consumer behavior is tilting toward home-stock preparedness, driven by post-pandemic self-testing habits, prompting Everlywell to close a USD 35 million Series D to scale DTC subscription boxes. Meanwhile, Germany’s Paul-Ehrlich-Institut harmonized CE requirements with the new ISO 23640:2023 stability standard, pushing exporters to reformulate colloidal-gold reagents before the July 2025 deadline.

Analyst Overview

The Blood Group Test Cards market outlook remains highly attractive, underpinned by double-digit growth in trauma care, pre-surgical screening and emerging-market insurance coverage. Competitive intensity is moderate—four multinationals control ~55 % share, yet nimble regional players win on price, creating recurring margin pressure. Over the next decade, demand will outstrip supply by 7–9 % CAGR as decentralized testing expands faster than manufacturing capacity; this imbalance supports pricing power for firms that can scale micro-fluidic card output. The innovation landscape is shifting from manual agglutination to AI-read, smartphone-linked cards, opening new IP moats and partnership models with digital-health platforms. Key risks include raw-material shortages for nitrocellulose membranes, tightening regulatory scrutiny in the EU and post-pandemic budget reprioritization in public hospitals. Strategics should invest now in vertically integrated production and digital assay portfolios to secure share before consolidation accelerates.

12 items

1. Executive Summary

2. Blood Group Test Cards Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Blood Group Test Cards Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Blood Group Test Cards Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Blood Group Test Cards Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Blood Group Test Cards Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Blood Group Test Cards Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Blood Group Test Cards Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Blood Group Test Cards Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Blood Group Test Cards Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Blood Group Test Cards Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Blood Group Test Cards Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Blood Group Test Cards Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Blood Group Test Cards Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Blood Group Test Cards Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Blood Group Test Cards Market Competition by Key Manufacturers

9.1. Global Blood Group Test Cards Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Blood Group Test Cards: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. InTec

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. ELDON BIOLOGICALS A/S

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. JAL Innovation

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Bio-Rad Laboratories

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Diagast SAS

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Haemokinesis

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Eastern Business Forms, Inc.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. BSBE

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. DexBio

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Blood Group Test Cards Market

Figure 4: Global Blood Group Test Cards Market: Drivers

Figure 5: Global Blood Group Test Cards Market: Challenges

Figure 6: Global Blood Group Test Cards Market: Trends

Figure 7: Global Blood Group Test Cards Market: Opportunity

Figure 8: Global Blood Group Test Cards Market: Restraint

Figure 9: Global Blood Group Test Cards Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Blood Group Test Cards Market Value (USD Million) By Region

Figure 19: Global Blood Group Test Cards Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Blood Group Test Cards Market Value (USD Million) By Region

Figure 27: Global Blood Group Test Cards Market Share (%) By: Regions (2032)

Figure 28: Global Blood Group Test Cards Market Volume (K) By Region

Figure 29: Global Blood Group Test Cards Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Blood Group Test Cards Market Value (USD Million) By Region

Figure 37: Global Blood Group Test Cards Market Share (%) By: Regions (2032)

Figure 38: Global Blood Group Test Cards Market Volume (K) By Region

Figure 39: Global Blood Group Test Cards Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Blood Group Test Cards Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Blood Group Test Cards Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Blood Group Test Cards Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Blood Group Test Cards Market Value (USD Million) By Region

Table 14: Global Blood Group Test Cards Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Blood Group Test Cards Market Volume (K) By Region

Table 31: Global Blood Group Test Cards Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Blood Group Test Cards Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Blood Group Test Cards Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Blood Group Test Cards Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: InTec Basic Information And Sales Area

Table 52: InTec. Products Portfolio

Table 53: ELDON BIOLOGICALS A/S Basic Information And Sales Area

Table 54: ELDON BIOLOGICALS A/S. Products Portfolio

Table 55: JAL Innovation Basic Information And Sales Area

Table 56: JAL Innovation. Products Portfolio

Table 57: Bio-Rad Laboratories Basic Information And Sales Area

Table 58: Bio-Rad Laboratories. Products Portfolio

Table 59: Diagast SAS Basic Information And Sales Area

Table 60: Diagast SAS. Products Portfolio

Table 61: Haemokinesis Basic Information And Sales Area

Table 62: Haemokinesis. Products Portfolio

Table 63: Eastern Business Forms, Inc. Basic Information And Sales Area

Table 64: Eastern Business Forms, Inc.. Products Portfolio

Table 65: BSBE Basic Information And Sales Area

Table 66: BSBE. Products Portfolio

Table 67: DexBio Basic Information And Sales Area

Table 68: DexBio. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Type

Table 70: Global Market Share (%) By Type (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Type

Table 74: Global Market Share (%) By Type (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Blood Group Test Cards Market Value (USD Million) By Region

Table 78: Global Blood Group Test Cards Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Type

Table 81: North America Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Type

Table 84: Europe Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Type

Table 90: South America Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 94: Global Blood Group Test Cards Market Volume (K) By Region

Table 95: Global Blood Group Test Cards Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Type

Table 98: North America Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Type

Table 101: Europe Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Type

Table 107: South America Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

FAQs

1. What is the current Blood Group Test Cards market size?

Global Blood Group Test Cards market size surpassed USD 1.3 billion in 2023, powered by rising surgical volumes, pre-transfusion screening protocols, and expanding point-of-care diagnostics across emerging economies.

2. What growth forecast defines the future outlook to 2030?

Analysts project a 6.2% CAGR through 2030, lifting the market toward USD 2.1 billion as hospitals, blood banks, and ambulance fleets replace tube-based methods with rapid, room-temperature-stable cards.

3. Which key drivers are accelerating adoption?

Drivers include escalating trauma cases, OB emergencies, voluntary blood donation campaigns, reimbursement for pre-operative typing, and the shift to near-patient testing that reduces lab turnaround time.

4. What operational challenges restrain faster uptake?

High card cost per test, cold-chain requirements for monoclonal reagents, false-negative risk from weak antigens, and uneven regulatory harmonization create procurement hesitancy among price-sensitive public sectors.

5. Which regions lead consumption and innovation?

North America holds 38% share driven by AABB standards; Europe follows with CE-marked cards, while India and China post fastest volume growth owing to government-led blood safety programs.

6. Who are the top companies shaping competitive dynamics?

Bio-Rad, Thermo Fisher, Rapid Labs, Cardinal Health, and Atlas Medical dominate through extensive blood-typing portfolios, global distribution, and new gel-card automation that integrates with LIS platforms.

7. Where do future opportunities lie?

Opportunity pockets include at-home maternity cards, military forward-deployment kits, and multiplex molecular-serological hybrids that deliver Rh-Kell phenotyping in under five minutes without electricity.

8. How is technology impact reshaping product design?

Microfluidic channels, lyophilized reagents, smartphone AI readers, and blockchain traceability are shrinking card size, extending shelf life, and enabling real-time quality documentation across blood supply chains.

9. What does the regulatory landscape demand?

FDA class II 510(k) clearance, EU IVDR technical files, and WHO prequalification now require clinical sensitivity data for weak D variants, pushing manufacturers toward prospective trials of 10,000+ donor samples.

Contact for Full Report

Loading report content...

Blood Group Test Cards Size, Share & Forecast Analysis 2025–2033

Market Snapshot

Blood Group Test Cards Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Blood Group Test Cards Segmentation

Blood Group Test Cards Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Blood Group Test Cards market size?

2. What growth forecast defines the future outlook to 2030?

3. Which key drivers are accelerating adoption?

4. What operational challenges restrain faster uptake?

5. Which regions lead consumption and innovation?

6. Who are the top companies shaping competitive dynamics?

7. Where do future opportunities lie?

8. How is technology impact reshaping product design?

9. What does the regulatory landscape demand?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Blood Group Test Cards Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Blood Group Test Cards Segmentation

Blood Group Test Cards Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Blood Group Test Cards market size?

2. What growth forecast defines the future outlook to 2030?

3. Which key drivers are accelerating adoption?

4. What operational challenges restrain faster uptake?

5. Which regions lead consumption and innovation?

6. Who are the top companies shaping competitive dynamics?

7. Where do future opportunities lie?

8. How is technology impact reshaping product design?

9. What does the regulatory landscape demand?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation